Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05887375 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery

StatusCompleted
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Results posted: Oct 7, 2026 Show 5 more changesShow less
    • Primary endpoint revised
    • Eligibility criteria expanded, about 15 words
    • Secondary endpoints revised (5)
    • Collaborators: details revised at 1 of 1 entry
    • Publications: details revised at 5 of 6 entries
  2. Trial status: Enrolling by Invitation to Completed
    • Primary completion date changed from estimate of Dec 2025 to Jan 15, 2026
    • Study completion date changed from estimate of Jun 2026 to Jan 15, 2026
    v5
  3. Primary completion date: Jul 2025 to Dec 2025
    • Study completion date: Sep 2025 to Jun 2026
    v4
  4. Primary completion date: Aug 2024 to Jul 2025
    • Study completion date: Sep 2024 to Sep 2025
    v3
  5. Trial status: Not Yet Recruiting to Enrolling by Invitationv2 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Primary completion date: Jul 2024 to Aug 2024
    • Study completion date: Aug 2024 to Sep 2024
    • Start date changed from estimate of Jul 2023 to Aug 3, 2023
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an active-comparator controlled study to evaluate the effect of sugammadex compared to neostigmine/glycopyrrolate for reversal of rocuronium on the incidence of urinary retention after subjects undergo elective ambulatory spine surgery.
Trial Details
NCT Number NCT05887375
Lead Sponsor University of Missouri-Columbia
Collaborators: Merck Sharp & Dohme LLC
Conditions
(from sponsor)		 Spine Surgery, Reversal of Neuromuscular Blockade, Urinary Retention Postoperative
Related terms Urinary Retention
Enrollment 118 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov